Apoptosis inducer 20
Apoptosis inducer 20 (12) causes G2/M cell cycle arrest and induction of apoptosis via caspase 3/7 activation, which occurred during M arrest. Apoptosis inducer 20 is a novel indolic benzenesulfonamide with anti-proliferative effect against a broad panel of cancer cell lines, which is proming for research of new anti-mitotic agents.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C20H21N3O5S
- 分子量:415.46
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A-375 | IC50 |
22.1 nM
Compound: 12
|
Antiproliferative activity against human A-375 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human A-375 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| BT-474 | IC50 |
68.3 nM
Compound: 12
|
Antiproliferative activity against human BT-474 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human BT-474 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| CAKI-1 | IC50 |
56.2 nM
Compound: 12
|
Antiproliferative activity against human CAKI-1 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human CAKI-1 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| HEK293 | IC50 |
23.4 nM
Compound: 12
|
Antiproliferative activity against human HEK293 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human HEK293 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| HeLa | IC50 |
1.7 nM
Compound: 12
|
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 38959729] |
| HeLa | IC50 |
11 nM
Compound: 12
|
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| HeLa | IC50 |
16.3 nM
Compound: 12
|
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 72 hrs in presence of verapamil by MTT assay
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 72 hrs in presence of verapamil by MTT assay
|
[PMID: 38959729] |
| HeLa | IC50 |
22.3 nM
Compound: 12
|
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 72 hrs in absence of verapamil by MTT assay
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 72 hrs in absence of verapamil by MTT assay
|
[PMID: 38959729] |
| HT-1080 | IC50 |
9.9 nM
Compound: 12
|
Antiproliferative activity against human HT-1080 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human HT-1080 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| MCF7 | IC50 |
13.7 nM
Compound: 12
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| MDA-MB-468 | IC50 |
13 nM
Compound: 12
|
Antiproliferative activity against human MDA-MB-468 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human MDA-MB-468 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| MES-SA | IC50 |
8.9 nM
Compound: 12
|
Antiproliferative activity against human MES-SA cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human MES-SA cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| TERT-RPE1 | IC50 |
80.4 nM
Compound: 12
|
Antiproliferative activity against human RPE-1 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human RPE-1 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
Apoptosis inducer 20 inhibits cell growth activity in different cancer cell lines. The melanoma cell-line MelMet5 is the most sensitive cell-line, followed by HeLa[1].
Apoptosis inducer 20 (100 nM, 24 h) causes G2/M cell cycle arrest and induction of apoptosis via caspase 3/7 activation in MES-SA cells[1].
Antiproliferative IC50 values of active sulfonamides on HeLa, MCF7, BT-474, MDA-MB468, MES-SA, HT-1080, MelMet5, A375, WM-1366, and Caki1 cancer cell lines[1]
| HeLa | MCF7 | BT-474 | MDA-MB468 | MES-SA | HT-1080 | MelMet5 | A375 | WM-1366 | Caki1 | |
| 12 | 11.0 | 13.7 | 68.3 | 13.0 | 8.9 | 9.9 | 8.9 | 22.1 | 52.8 | 56.2 |